百傲化学内控缺陷被责令改正 目前19.3%总股本被质押

Core Viewpoint - The China Securities Regulatory Commission (CSRC) has imposed corrective measures on Dalian Baiao Chemical Co., Ltd. due to internal control deficiencies, specifically in financial management, procurement management, and contract management [1][4][5]. Group 1: Internal Control Issues - Dalian Baiao Chemical and its wholly-owned subsidiary, Shenyang Baiao Chemical, have been found to have issues in their internal controls regarding financial management [1][4]. - The company also has deficiencies in its procurement management internal controls [1][4]. - Additionally, there are problems with the internal controls related to contract management [1][4]. Group 2: Regulatory Actions - The Dalian Securities Regulatory Bureau has decided to take administrative regulatory measures against Baiao Chemical, which will be recorded in the securities and futures market integrity archives [2][5]. - Warning letters have been issued to Chairman Liu Xianwu and Chief Financial Officer Wang Xiliang, which will also be recorded in the integrity archives [2][5]. Group 3: Shareholder Pledge Information - As of August 15, 2025, Baiao Chemical has a total of 13,627.68 million shares pledged, which accounts for 19.30% of the total share capital [2][3].